BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8990091)

  • 1. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
    Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
    Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal anti-DNA antibodies: structure, specificity, and biology.
    Marion TN; Krishnan MR; Desai DD; Jou NT; Tillman DM
    Methods; 1997 Jan; 11(1):3-11. PubMed ID: 8990083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The site and stage of anti-DNA B-cell deletion.
    Chen C; Nagy Z; Radic MZ; Hardy RR; Huszar D; Camper SA; Weigert M
    Nature; 1995 Jan; 373(6511):252-5. PubMed ID: 7816141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies.
    Tsao BP; Chow A; Cheroutre H; Song YW; McGrath ME; Kronenberg M
    Eur J Immunol; 1993 Sep; 23(9):2332-9. PubMed ID: 8370409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.
    Zack DJ; Yamamoto K; Wong AL; Stempniak M; French C; Weisbart RH
    J Immunol; 1995 Feb; 154(4):1987-94. PubMed ID: 7836777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repertoire cloning of lupus anti-DNA autoantibodies.
    Roben P; Barbas SM; Sandoval L; Lecerf JM; Stollar BD; Solomon A; Silverman GJ
    J Clin Invest; 1996 Dec; 98(12):2827-37. PubMed ID: 8981931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of allelic exclusion permits autoreactive B cells to escape deletion.
    Iliev A; Spatz L; Ray S; Diamond B
    J Immunol; 1994 Oct; 153(8):3551-6. PubMed ID: 7930577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies.
    Zhang W; Reichlin M
    Clin Immunol; 2005 Dec; 117(3):214-20. PubMed ID: 16290070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
    Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
    J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice.
    Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP
    Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
    Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
    Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.
    Muryoi T; Sasaki T; Harata N; Takai O; Tamate E; Yoshinaga K
    Clin Exp Immunol; 1988 Jan; 71(1):67-72. PubMed ID: 3258206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
    James JA; Harley JB
    J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.